Ibuprofen unsafe for treating simple UTIs: Study

Image
IANS London
Last Updated : May 16 2018 | 3:30 PM IST

Commonly used painkiller Ibuprofen may not be a safer alternative to antibiotics for women suffering from simple urinary tract infection, a study says.

Various studies have suggested that treatment with non-steroidal anti-inflammatory drugs such as Ibuprofen may support recovery of a urinary tract infection, raising the possibility that the use of antibiotics could be reduced.

However, the new study revealed that it is not safe to recommend Ibuprofen instead of antibiotics in uncomplicated cystitis, due to the increased risk of developing a serious upper urinary tract infection.

Using Ibuprofen could lead to longer duration of symptoms and more serious adverse events related to the spread of the primary infection.

"Initial treatment with Ibuprofen could reduce unnecessary use of antibiotics. However, until we can identify those women in need of antibiotic treatment to prevent complications, we cannot recommend Ibuprofen alone to women with uncomplicated UTIs," said researchers including Ingvild Vik from the University of Oslo in Norway.

For the study, detailed in the journal PLOS Medicine, the team randomised 383 women with uncomplicated urinary tract infections to receive either standard treatment of antibiotics for three days or Ibuprofen as a symptomatic treatment without an antimicrobial effect.

The results showed that women assigned to receive Ibuprofen without antibiotics took three days longer to get well on an average.

Further, among women in the Ibuprofen group, twelve (6.6 per cent) developed a febrile urinary tract infection, with a smaller proportion (3.9 per cent) developing a serious kidney infection which did not occur in the antibiotics group, the researchers noted.

--IANS

rt/mag/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 16 2018 | 3:24 PM IST

Next Story